-
Quinine dihydrochloride
- CAS:60-93-5
- MW:397.3
- MF:C20H26Cl2N2O2
Quinine dihydrochloride, with the chemical formula C20H24N2O2·2HCl, has the CAS number 60-93-5. It appears as a white crystalline powder with a bitter taste. Quinine dihydrochloride is a natural alkaloid derived from the bark of the cinchona tree. Its basic structure consists of a quinoline ring system with various functional groups attached. This compound is soluble in water and slightly soluble in alcohol. Quinine dihydrochloride is commonly used as an antimalarial drug and also has analgesic and antipyretic properties. It is important to note that quinine dihydrochloride should be used under medical supervision and its use may be associated with certain side effects. It is recommended to consult a healthcare professional before using this compound.
Applicable Fields
Antimalarial: Quinine dihydrochloride is primarily used as an antimalarial drug. Its mechanism of action involves inhibiting the growth and reproduction of the malaria parasite within the red blood cells. Quinine dihydrochloride is effective against various species of Plasmodium, the causative agent of malaria. It is often used in combination with other antimalarial drugs to enhance efficacy and reduce the risk of drug resistance.
Muscle Relaxant: Quinine dihydrochloride also has muscle relaxant properties. It can be used to treat muscle cramps and spasms, particularly those associated with conditions such as nocturnal leg cramps. The exact mechanism of action for its muscle relaxant effects is not fully understood, but it is believed to involve modulation of calcium channels and inhibition of muscle contractions.
Storage
Conditions: Store in a cool and dry place, away from direct sunlight.
Poison by intravenous and subcutaneous routes. Moderately toxic by ingestion. Mutation data reported. When heated to decomposition it emits very toxic fumes of NOx and HCl. Safety Information of Quinine dihydrochloride (CAS NO.60-93-5) is:
Hazard Codes: Xi
Risk Statements: 36/37/38
36/37/38: Irritating to eyes, respiratory system and skin
Safety Statements: 26-36
26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice 36: Wear suitable protective clothing
RIDADR: 1544
HazardClass: 6.1(b)
PackingGroup: III
Quinine dihydrochloride , its cas register number is 60-93-5. It also can be called (-)-Quinine dihydrochloride ; Acid quinine hydrochloride ; Chinindihydrochlorid ; Quinine HCl ; Cinchonan-9-ol, 6'-methoxy-, dihydrochloride, (8-alpha,9R) (9CI) ; (6-Methoxy-4-quinolyl)(5-vinyl-1-azabicyclo[2.2.2]oct-2-yl)methanol dihydrochloride .It is a white solid.
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
child | TDLo | intravenous | 630mg/kg/1W-I (630mg/kg) | SENSE ORGANS AND SPECIAL SENSES: "RETINAL CHANGES (PIGMENTARY DEPOSITIONS, RETINITIS, OTHER): EYE" SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE GASTROINTESTINAL: NAUSEA OR VOMITING |
Japanese Journal of Ophthalmology. Vol. 28, Pg. 409, 1984. |
guinea pig | LD50 | intravenous | 57mg/kg (57mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD |
Journal of Pharmacology and Experimental Therapeutics. Vol. 91, Pg. 157, 1947. |
guinea pig | LDLo | subcutaneous | 199mg/kg (199mg/kg) | Proceedings of the Society for Experimental Biology and Medicine. Vol. 32, Pg. 595, 1935. | |
mouse | LD50 | intravenous | 86mg/kg (86mg/kg) | Biochemical Journal. Vol. 28, Pg. 426, 1934. | |
mouse | LD50 | oral | 660mg/kg (660mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 91, Pg. 157, 1947. | |
rabbit | LD50 | intravenous | 35mg/kg (35mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) | Journal of Pharmacology and Experimental Therapeutics. Vol. 91, Pg. 157, 1947. |
rabbit | LD50 | oral | 641mg/kg (641mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 91, Pg. 157, 1947. | |
rat | LD50 | intravenous | 78mg/kg (78mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD |
Journal of Pharmacology and Experimental Therapeutics. Vol. 91, Pg. 157, 1947. |
rat | LD50 | oral | 1392mg/kg (1392mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 91, Pg. 157, 1947. |
|
|
|
|